|
USP6NL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.016500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.774000E-04 |
| Normal-vs-Stage2 |
6.233800E-01 |
| Normal-vs-Stage3 |
7.782300E-02 |
| Normal-vs-Stage4 |
1.004970E-01 |
| Stage1-vs-Stage2 |
6.957300E-03 |
| Stage1-vs-Stage3 |
2.547000E-01 |
| Stage1-vs-Stage4 |
2.780400E-01 |
| Stage2-vs-Stage3 |
7.196400E-02 |
| Stage2-vs-Stage4 |
7.538000E-02 |
| Stage3-vs-Stage4 |
9.939800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.299220E-03 |
| Normal-vs-AfricanAmerican |
8.317700E-02 |
| Normal-vs-Asian |
2.182300E-02 |
| Caucasian-vs-AfricanAmerican |
9.229800E-01 |
| Caucasian-vs-Asian |
8.555000E-01 |
| AfricanAmerican-vs-Asian |
9.702600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.418250E-01 |
| Normal-vs-Female |
2.382700E-03 |
| Male-vs-Female |
1.786170E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.230500E-04 |
| Normal-vs-Age(41-60Yrs) |
6.898400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.016400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.958600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.492080E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.057800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.731640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.182000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.748200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.076800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.470600E-01 |
| Classical-VS-Follicular |
5.89528426075958E-14 |
| Classical-VS-Other |
6.339600E-01 |
| Classical-VS-Normal |
2.20039999999644E-05 |
| Tall-VS-Follicular |
3.2006999994838E-07 |
| Tall-VS-Other |
5.054800E-01 |
| Tall-VS-Normal |
4.380200E-03 |
| Follicular-VS-Other |
1.982350E-01 |
| Follicular-VS-Normal |
1.187930E-02 |
| Other-VS-Normal |
5.248800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.970400E-01 |
| Normal-vs-N1 |
7.314000E-02 |
| N0-vs-N1 |
2.985600E-01 |
|
|
